Antileishmanial activity of conventional and solid lipid nanoparticles of Amphotericin B on Leishmania major.

CONCLUSION: Discovery of new effective drugs based on nanocarriers, such as SLN, is practical and opens a new window for the treatment of CL. More studies are needed in the future.
PMID: 31613731 [PubMed - as supplied by publisher]

Source: Infectious Disorders Drug Targets - October 14, 2019 Category: Infectious Diseases Authors: Soltani S, -Forushani HM, Soltani S, Kahvaz MS, Foroutan M Tags: Infect Disord Drug Targets Source Type: research